Samsrita Labs Ltd. (SAMSRITA)
Market Open
11 Aug, 22:00
MSE MSE Primary ₹
11. 50
+0.5
+4.5455%
₹
379.69M Market Cap
- P/E Ratio
- Div Yield
15,025 Volume
0 Eps
₹ 11
Previous Close Want to track SAMSRITA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
SAMSRITA trading today higher at ₹11.5, an increase of 4.5455% from yesterday's close, completing a monthly decrease of -2.5424% or -₹0.3. Over the past 12 months, SAMSRITA stock lost -44.605%.
SAMSRITA is not paying dividends to its shareholders.
The last earnings report, released on Apr 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
SAMSRITA Chart
People also search for
Samsrita Labs Ltd. (SAMSRITA) FAQ
What is the stock price today?
The current price is ₹11.50.
On which exchange is it traded?
Samsrita Labs Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is SAMSRITA.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 379.69M.
Has Samsrita Labs Ltd. ever had a stock split?
No, there has never been a stock split.
Samsrita Labs Ltd. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | - CEO | MSE Exchange | INE579N01018 ISIN |
| India Country | 4 Employees | - Last Dividend | - Last Split | - IPO Date |
Samsrita Labs Ltd. is a prominent player in the pharmaceutical industry, specializing in the research, development, and manufacturing of high-quality pharmaceutical products. The company is dedicated to innovation in healthcare, actively engaging in the creation of a diverse portfolio of generic and proprietary medicines. Samsrita Labs focuses on areas such as oncology, cardiovascular, and diabetes care, striving to address critical health challenges and improve patient outcomes globally. With a robust research pipeline and state-of-the-art manufacturing facilities, the company ensures the delivery of effective and safe medications. Samsrita Labs Ltd. serves a broad market, providing solutions to both individual patients and large healthcare institutions. As a significant participant in the pharmaceutical sector, it plays a vital role in expanding access to affordable healthcare solutions, contributing to the global healthcare landscape by improving the quality of life for patients worldwide.
Contact Information
Address: 6-3-354/13/B2, Suryateja Apartments
Phone: 91 33 2243 6242
Website: https://drhlsl.com
